This study was designed to retrospectively compare the impact of crude Sigma V collagenase (Sigma V, n = 52) with high-purified Serva NB1 collagenase (Serva NB1, n = 42) on human islet isolation outcomes. A three-step filtration was applied to the crude Sigma V to remove endotoxin contamination and impurities; in addition, this process was used as a lot prescreening tool. Isolation outcomes were determined by digestion efficacy, islet yields, purity, viability, glucose-stimulated insulin release, and endotoxin content. The digestion efficacy between Sigma V and Serva NB1 was statistically significant (Sigma V: 64.71% vs. Serva NB1: 69.71%, p = 0.0014). However, the islet yields were similar (Sigma V: 23422.58 vs. Serva NB1: 271097 IEq, p = 0.23) between groups. There was no significant purity difference observed in fractions with purities greater than 75%. Viability (Sigma V: 93.3% vs. Serva NB1: 94.8%, p = 0.061) and stimulation indexes (Sigma V: 3.41 vs. Serva NB1: 2.74, p = 0.187) were also similar between the two groups. The impact of cold ischemia and age on the isolation outcome in the Sigma V group was comparable to the Serva NB1 group. The endotoxin content of the final products in the filtered Sigma V group was significantly less than that in the high-purified Serva NB1 group (0.022 vs. 0.052 EU/ml, p = 0.003). Additionally, in the Sigma V group there was minimal lot to lot variation and no significant loss of enzymatic activity after filtration. These findings indicate that the use of Sigma V or other crude enzyme blends for research pancreata is warranted to reduce isolation costs and increase the amount of islets available for critical islet research. These findings also validate the need for a systematic enzyme analysis to resolve these inconsistencies in overall enzyme quality once and for all.
INTRODUCTION
NB1) have been the most widely investigated enzymes for human islet isolation. Prior to 2007, Liberase HI was considered the gold standard enzyme for more than 10 Human islet transplantation is an emerging therapy for type I diabetes (11, 13, 27) . One of the main limiting years (14, 19, 20, 26) . However, following disclosure that it potentially contained bovine neural tissue contamifactors for wide-spread clinical application is inconsistent islet isolation outcomes. The quality of the enzyme nants, Liberase HI was discontinued for use in clinical islet transplantations. To reduce the risk of transmission used to dissociate the pancreas is of great importance for islet manufacturing. Significant global efforts to puof bovine spongiform encephalopathy, the islet community began to use Serva NB1. However, this enzyme rify the components of collagenase and protease enzyme blends and to characterize the in vitro enzyme composichange significantly increased islet isolation cost and decreased human islet isolation outcomes worldwide (1, 9) . tion and digestion efficacy have been made; however, wide batch-to-batch, and even vial-to-vial, variability
Before the introduction of Liberase HI, Sigma Collagenase V (Sigma V) and other crude Sigma collagenase remains (23) . This variability in enzyme blends has hindered the standardization of collagenase digestion in blends were used for both human and other animal pancreatic islet isolations (29,30). However, these enzyme human islet isolation across centers and is associated with unpredictable islet isolation results (7,9,16). In the blends did not gain extensive application due to low digestion efficacy related to enzyme impurity, imbalanced past, Liberase HI and Serva NB1 collagenase (Serva combination of key active components, significant
To reduce endotoxin and pigment levels, the reconstituted enzyme went through a three-step filtration process batch-to-batch and vial-to-vial enzyme variation, high endotoxin levels, and pigment contamination (17, 29, 30) . using decreasing pore size filters (0.8, 0.45, and 0.22 µm) at 2-10°C. The crude enzyme was filtrated with Yet, most of the results regarding the use of the collagenase enzyme blends in human islet isolation were three cellulose nitrate-based filters (500 ml volume, Nalgene) using a standard "wall vacuum" at a pressure of obtained long before the optimization of current standard isolation techniques (29). In this study, we investi-16-17 lb/inch 2 . To reduce filtration variance, the same types of filters were used for every filtration step. gated whether simple filtration of the low-cost crude collagenase, Sigma V, combined with lot screening, Throughout these isolations, multiple lots of cellulose nitrate-based filters were used with comparable results. could represent an alternative to expensive purified enzyme blends.
The three-step filtration process was also used as a prescreening tool for enzyme lot selection. When testing a MATERIALS AND METHODS new lot of Sigma V, the enzyme was used only when at Pancreas Preservation and Islet Isolation least 250-300 ml of enzyme passed through the first 0.8-µm filter and the rest passed through an additional Human pancreata were obtained from organ procurement organizations following informed consent and IRB 0.8-µm filter. In the case where the membrane became blocked before 200 ml of enzyme passed through the approval. The pancreata were preserved, using either University of Wisconsin solution (UW) or Histidinefilter, the lot was discarded and not used for islet isolations. In our experience, if the enzyme passed through Tryptophan-Ketoglutarate (HTK), and transported to the cell isolation facility at the University of Illinois at Chithe initial 0.8-µm filters, there were no subsequent problems with the additional filters to complete the threecago. No donor randomization was applied.
Fifty-two isolations were performed using Sigma step filtration process. Approximately 40% of the enzymes tested did not make it through the filtration screening. Collagenase V and 42 isolations were performed using Serva NB1 purified enzyme blend. In order to reduce However, when the enzyme passed through our easy filtration process, it was successfully used for human islet the variability due to differences in isolation procedures, only the isolations conducted in the period between June isolations every time. Therefore, we did not have to waste any pancreata or time testing these enzymes. 2007 and December 2009 were compared. The same islet isolation protocol was used for all isolations during
The isolation, purification, and culture procedures were performed as previously described (13, 18, 25, 27) . this time. Serva NB1 (Premium and GMP grades, SERVA Electrophoresis GmbH, Heidelberg, Germany) Briefly, the pancreata were trimmed and distended with either Serva NB1 or Sigma V enzymes and digested was reconstituted with cold HBSS (Mediatech, Manassas, VA), supplemented with 10 U/ml heparin, and comusing a modified Ricordi semiautomatic method. The digestion phase was stopped between 10 and 20 min plemented with neutral protease (SERVA Electrophoresis GmbH). Variable units of collagenase (1600-2057 based on microscopic observation of islet cleavage (degree of islets released from exocrine tissue) and Wunsch units) and neutral protease (200-257 units) were used based on the pancreas weights. Sigma V, with tissue volume by the same experienced personnel. Digested tissues were then collected and washed three an enzyme activity of FALGPA 1.0-3.0 mg/solid (Sigma, St. Louis, MO), was reconstituted with 350 ml times. The tissues were incubated with UW solution for 30 min prior to continuous density purification using the of perfusion solution (Mediatech), which was supplemented with 20 mM of HEPES (Mediatech) and 10 mM UIC-UB gradient (4) in a Cobe 2991 cell separator (Cobe 2991, Cobe, CO) and subsequently cultured in of glutamine (Invitrogen, Carlsbad, CA), to a final concentration of 2.86 mg/ml. There is no direct conversion CMRL culture media (Mediatech) at 37°C supplemented with ITS (Invitrogen), sodium bicarbonate (Sigma), between Wunsch units used for the Serva enzyme to the FALGPA units used for the Sigma V enzyme. This con-HEPES, human albumin (Grifols, Los Angeles, CA), and ciprofloxacin (Hospira Inc., Lake Forest, IL). centration was chosen based on results from previous rodent and monkey studies (2, 21) . No additional neutral Islet Quality Score protease was used in the preparation of Sigma V. Each lot of Sigma V has an associated certificate of origin, Final quality of isolated human islets was scored using a standardized system based on size distribution, tracking and certifying the source animals as disease free in antemortem and postmortem testing; no bovine fragmentation, density, border sharpness, and shape (22) . Each of these criteria was scored from 0 to 2. Islets neural material is used in the manufacturing of Sigma V. This enzyme is also heat-treated twice to inactivate of maximal quality scored 10; islets of poorest quality scored 0. potential pathogenic viral agents.
Glucose-Stimulated Insulin Secretion Islet Isolation Outcomes and Viability Assays
A comparison of outcome variables from human islet Static glucose incubations (GSI) were performed, as isolations using either the Sigma V or the Serva NB1 previously described, to evaluate islet physiology and enzymes is summarized in Table 2 . The time required potency (3). Briefly, 10 purified islets were hand-picked to free the majority of the islets from the surrounding and incubated with Krebs ringer buffer containing 1.67 exocrine tissue was not different between the Sigma V mM (low) glucose and 20 mM HEPES for 1 h. The and the Serva NB1 groups. Enzyme digestion efficacy islets were then transferred into new Krebs buffer conwas calculated by dividing the weight of the digested taining 16.7 mM (high) glucose for 1 h and insulin tissue by total pancreas weight. The difference in digesconcentration was determined using a conventional tion efficacy between Serva NB1 and Sigma V was staenzyme-linked immunosorbent assay (ELISA, Mercotistically significant (69.71 ± 23.74% vs. 64.71 ± 19.12%, dia, Sweden). The stimulation index (SI) was calculated p < 0.05). However, when we compared pre-and postpuby dividing insulin release during high glucose (16.7 rification yields, the mean islet equivalents (IEq) of the mM) by insulin release during basal glucose (1.67 mM).
Sigma V group was very similar to the yields of the Serva The postisolation islet viability was determined using NB1 group. Also pre-and postpurification islet yield per fluorescent staining with Syto-Green (Invitrogen) and gram of pancreas were comparable among the groups. ethidium bromide (Sigma), as previously described Successful separation of islets from exocrine tissue (5,24,31).
using a continuous density gradient depends on several factors, such as the percentage of free islets and the difEndotoxin Measurement ference in cell density between islets and exocrine cells. Endotoxin content was measured in the Sigma V The percentage of free islets in the Sigma V group after enzyme after filtration and in the final islet preparation digestion was similar to the Serva NB1 group. In addiusing the Endosafe Portal Test System (PTS TM , Charles tion, we further compared the purification outcomes by River Laboratory). Similar testing was done with the evaluating the distribution of islet purity and tissue volServa enzyme in order to compare endotoxin levels ume. Each collection fraction showed a similar distribubefore use and in the final islet product. In brief, 1.0 ml tion pattern and volume between the two groups (Fig. of enzyme or final islet product was spun down for 10 1A, B). With regard to differences in purity of the fracs, using a bench centrifuge at 1000 rpm. Supernatants tions, only the purest fraction displayed a lower value in (25 µl) were injected into cartridges provided by Charles the Sigma V group compared to the Serva NB1 group River in triplicates. Readouts were expressed as EU/ml.
(82.1 ± 13.6% vs. 87.3 ± 7.58%, p < 0.05), while all the remaining fractions presented similar purity. After puriStatistical Analysis fication, islets were divided into three groups accordAll results were expressed as either mean ± SD or ingly to purity. The "high purity group" had purity SE. Differences between Sigma V and Serva NB1 were greater or equal to 75%, the "middle purity group" had analyzed by paired or unpaired Student's t-tests and chipurity between 74% and 40%, and the "low purity square tests. Statistical analysis for multiple comparigroup" had purity less than 40%. No significant differsons between Sigma V lots were analyzed by one-way ence was observed for fractions with purities greater ANOVA. Level of statistical significance for most analthan 75% (Fig. 1C) . Overall, these data indicated that yses was set at p < 0.05; multiple comparisons using the purity differences did not affect the islet recovery ANOVA were considered significant at p < 0.01. rate during the purification process. The islet recovery rate, which was calculated by dividing the prepurifica-RESULTS tion by the postpurification yield, was 82.01 ± 41.70% Human Pancreata Characteristics in the Sigma V group and 78.65 ± 36.73% in the Serva NB1 group (p > 0.05). Pancreas characteristics are shown in Table 1 . Donor Sigma V and Serva NB1 groups represented a similar age, gender, weight, and body mass index did not show size distribution (Fig. 2) . The ratio of actual islet number any significant differences between the two groups. The (AIN) to islet equivalent number (IEN), an indicator of percentage of organs preserved in UW or HTK soluislet fragmentation, was also assessed to compare islet tions, which are used for organ flush and cold storage, preparations digested with Sigma V or Serva NB1. This was also similar between groups. The only significant analysis revealed a similar ratio between the two groups difference observed was cold ischemia time, which was (0.91 ± 0.03 of Sigma V vs. 0.89 ± 0.04 of Serva NB 1, significantly higher for the Sigma V group (10.63 ± 2.0 p > 0.05). h vs. Serva NB1 9.32 ± 2.95 h group, p = 0.023). Tissue specificity and age difference are also imporhigher compared to Serva enzymes (49.50 ± 13.03 vs. 17.10 ± 3.84 EU/ml, p < 0.014). Postisolation endotoxin tant factors in determining the efficacy of collagenase digestion dissociation. Comparison of postpurification levels were not significantly different (0.044 ± 0.042 EU/ml Sigma vs. 0.031 ± 0.016 EU/ml Serva). Overall, yields of three age groups revealed no significant difference between Sigma V and Serva NB1 (Fig. 3A) . The comparison of the 94 isolations in this study demonstrated that the Sigma V endotoxin levels were signifiassociation of cold ischemia and isolation outcomes was compared between the Sigma V and the Serva NB1 cantly lower than the Serva NB1 group (0.022 ± 0.026 vs.0.052 ± 0.006 EU/ml, p < 0.003) ( Table 3 ). groups and no significant difference was observed in either short or prolonged ischemia groups (Fig. 3B) .
Lot-to-Lot Variation of Sigma V Performance on Isolation Outcomes Islet Quality
A comparison of islet quality among the Sigma V Table 4 summarizes the isolation outcomes of four different lots of Sigma V. After our filtration process and Serva NB1 groups is summarized in Table 3 . These results show similar values for stimulation indexes, as and lot screening, we only observed minimal lot-to-lot differences. measured by static glucose incubations, and viability assessments, as measured with inclusion and exclusion DISCUSSION dyes. In our FDA application to use Sigma V in clinical isolations, we demonstrated in a small number of samEach year there are approximately 6,000 organ donors available in the US, although less than 1,500 are used ples (n = 3) that, although preisolation endotoxin levels of the filtered Sigma V enzyme were significantly for either whole pancreas transplantation or islet trans- plantation (28). Thousands of pancreata are not used these enzymes are very high. Since cost burden is one of the primary factors contributing to the low number of because of poor donor characteristics and/or economic concern for isolation cost. Some studies indicate that isolations performed annually in the US, it is important to maximize the utilization of pancreatic donors, not Liberase HI and Serva NB1 are superior over crude enzyme blends (17); however, the monetary cost of only for clinical transplantation but also for research and drug development. Therefore, if a crude and primitive The availability of reliable enzymes for pancreas digestion is the limiting factor in islet manufacturing. enzyme blend can perform at least equally as well as a highly purified enzyme, then using this crude blend for
The lack of lot-to-lot consistency and unpredictable inprocess enzyme activity continues to be the Achilles research pancreata is justified.
In this study, we evaluated the use of crude collagenheel of clinical islet transplantation. Enzyme lot testing is extremely expensive because it can only be completed ase as an alternative to expensive, highly purified enzyme blends for human islet isolations. With a simple on human pancreata during islet isolations. This inherently limits enzyme development for human islet isolathree-step filtration-purification approach, and a lot screening based on the ease of filtration, we were able tion. We developed a prescreening method using our three-step filtration, in which only those lots that pass to achieve comparable results, in terms of islet yields and quality, with Sigma V and Serva NB1.
easily through the three-step filtration process are tested in human islet isolations. As a result, Sigma V lot-to-lot The herein presented study was not randomized, but the donor and organ characteristics between the two variation was not as large in our experience, compared to other studies (30). tested groups were comparable for all the variables known to impact human islet isolation outcomes. Cold
Despite the use of costly manufacturing methods and a cGMP-conformed manufacturing environment, the ischemia time was found to be significantly longer for the organs tested with the Sigma V enzyme; however, it endotoxin levels in islet preparations processed with the Serva NB1 were higher than in the Sigma V group. This is unlikely that one hour of ischemia time is of clinical relevance. Additionally, a similar distribution and purity is remarkable, since only a simple three-step filtration process was used to purify the Sigma V. Recent studies of islet size was observed in the final product, indicating that neither cellular edema nor fragmentation was have demonstrated that endotoxin contamination of enzymes and the materials used during the islet isolation increased by the use of the crude collagenase Sigma V. 
